Skip to main content
NIH funding notice RFA-NS-20-013

White Matter Lesion Etiology of Dementia in the U.S. Including in Health Disparity Populations (U19 Clinical Trial not Allowed)

Closed on June 30, 2020.

Posted
December 30, 2019
Close date
June 30, 2020
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
1
1 new
First-year cost
$3,236,413
Institutions
1
1 contact PI

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. UNIVERSITY OF CALIFORNIA AT DAVIS1

Most frequent study sections

  1. Special Emphasis Panel (ZNS1 SRB-H (14))1
1 award under RFA-NS-20-013 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2020The Clinical Significance of Incidental White Matter Lesions on MRI Amongst a Diverse Population with Cognitive Complaints (INDEED)1U19NS120384-01Decarli, CharlesFornage, MyriamUNIVERSITY OF CALIFORNIA AT DAVIS, CAFirst-year cost $3,236,413Study section ZNS1
Newest fiscal year first, then first-year cost.

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-12-0.3.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.

RFA-NS-20-013: White Matter Lesion Etiology of Dementia in the U.S. Including in Health Disparity Populations (U19 Clinical Trial not Allowed) | ScienceDex | ConductScience